{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:36:42Z","timestamp":1790707002310,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4 Part 1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.ju.0000173919.28835.aa","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T09:30:00Z","timestamp":1126603800000},"page":"1242-1247","source":"Crossref","is-referenced-by-count":163,"title":["HAS A 3-FOLD DECREASED DOSE OF BACILLUS CALMETTE-GUERIN THE SAME EFFICACY AGAINST RECURRENCES AND PROGRESSION OF T1G3 AND TIS BLADDER TUMORS THAN THE STANDARD DOSE? RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL"],"prefix":"10.1097","volume":"174","author":[{"given":"JOS\u00c9 A.","family":"MART\u00cdNEZ-PI\u00d1EIRO","sequence":"first","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LUIS","family":"MART\u00cdNEZ-PI\u00d1EIRO","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EDUARDO","family":"SOLSONA","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAFAEL HERN\u00c1NDEZ","family":"RODR\u00cdGUEZ","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JES\u00daS MAR\u00cdA","family":"FERN\u00c1NDEZ G\u00d3MEZ","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARCELINO GONZ\u00c1LEZ","family":"MART\u00cdN","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JES\u00daS RODR\u00cdGUEZ","family":"MOLINA","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANABEL GIMENO","family":"COLLADO","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICOL\u00c1S","family":"FLORES","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SANTIAGO","family":"ISORNA","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARLOS","family":"PERTUSA","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIANO","family":"RABAD\u00c1N","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDER","family":"ASTOBIETA","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOS\u00c9 EMILIO","family":"CAMACHO","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SALVADOR","family":"ARRIBAS","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROSARIO","family":"MADERO","sequence":"additional","affiliation":[{"name":"From the La Luz Clinic (JAM-P), La Paz Hospital (LM-P, SA, RM) and Hospital de San Carlos (JRM), Madrid, Instituto Valenciano de Oncolog\u00eda (ES), Valencia, Valdecilla Hospital (RHR), Santander, Complejo Hospitalario de Oviedo (JMFG) and Hospital Juan Canalejo (MGM), La Coru\u00f1a, Hospital La Mancha (AGC), Alc\u00e1zar de San Juan, Hospital Civil de Basurto (NF) and Hospital de Cruces (CP), Bilbao, Hospital Negr\u00edn (SI), Las Palmas, Hospital de la Princesa (MR) and Hospital de Gald\u00e1cano (AA), Vizcaya and..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For CLUB UROL\u00d3GICO ESPA\u00d1OL de TRATAMIENTO ONCOL\u00d3GICO (CUETO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000173919.28835.aa_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Mart\u00ednez-Pineiro","year":"2002","journal-title":"BJU Int"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib2","article-title":"Low dose vs standard dose BCG therapy of superficial bladder cancer: final results of a phase 3 randomized trial","volume":"35","author":"Bassi","year":"1999","journal-title":"Eur Urol, suppl."},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-5347(17)37532-8","article-title":"Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer","volume":"147","author":"Morales","year":"1992","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005392-200102000-00011","article-title":"The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder","volume":"165","author":"Mack","year":"2001","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1464-410X.1995.tb07308.x","article-title":"Low-dose bacille Calmette-Guerin (BCG) therapy in superficial high-risk bladder cancer: a phase II study with the BCG strain Connaught Canada","volume":"75","author":"Mack","year":"1995","journal-title":"Br J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","article-title":"Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success","volume":"34","author":"Lebret","year":"1998","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","article-title":"Intravesical bacille Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7-year follow-up","volume":"54","author":"Hurle","year":"1999","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib8","first-page":"760","article-title":"Profilaxis de los tumores superficiales de vejiga T1 con 27 mg de BCG semanal durante 6 semanas","volume":"52","author":"Moyano Calvo","year":"1999","journal-title":"Arch Esp Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(05)67974-8","article-title":"Low-dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results","volume":"163","author":"Losa","year":"2000","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)67973-6","article-title":"Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations","volume":"163","author":"Lebret","year":"2000","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0022-5347(17)36724-1","article-title":"Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy","volume":"148","author":"Cookson","year":"1992","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib12","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0022-5347(01)66043-9","article-title":"Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder","volume":"155","author":"Zhang","year":"1996","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-410X.1997.00431.x","article-title":"Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome","volume":"80","author":"Herr","year":"1997","journal-title":"Br J Urol"},{"issue":"suppl.","key":"10.1097\/01.ju.0000173919.28835.aa_bib14","article-title":"Long term follow-up of 98 patients with T1G3 transitional cell carcinoma of the bladder treated with BCG","volume":"80","author":"Palou","year":"1997","journal-title":"Br J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","article-title":"Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience","volume":"59","author":"Pansadoro","year":"2002","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","article-title":"Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours","volume":"41","author":"Patard","year":"2002","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","article-title":"A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival","volume":"169","author":"Shahin","year":"2003","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib18","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib19","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000173919.28835.aa_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","article-title":"Bladder Cancer Clinical Guidelines Panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis)","volume":"162","author":"Smith","year":"1999","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534701685835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534701685835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000173919.28835.aa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:51:01Z","timestamp":1651215061000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000173919.28835.aa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":20,"journal-issue":{"issue":"4 Part 1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1097\/01.ju.0000173919.28835.aa"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000173919.28835.aa","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}